Exact Mass: 465.1999

Exact Mass Matches: 465.1999

Found 145 metabolites which its exact mass value is equals to given mass value 465.1999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

S9947

2-(Benzyloxycarbonylaminomethyl)biphenyl-2-carboxylic acid 2-(2-pyridyl)ethylamide

C29H27N3O3 (465.2052)


   

Biotripyrrin-a

3-[(2E)-2-{[3-(2-carboxyethyl)-5-{[(2E)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methylidene}-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-3-yl]propanoic acid

C25H27N3O6 (465.19)


Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247

   

Biotripyrrin-b

3-(2-{[(2Z)-3-(2-carboxyethyl)-5-hydroxy-4-methyl-2H-pyrrol-2-ylidene]methyl}-5-{[(2E)-4-ethenyl-5-hydroxy-3-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoate

C25H27N3O6 (465.19)


Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247

   

Acalabrutinib

4-{8-amino-3-[1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide

C26H23N7O2 (465.1913)


   

Benzylpenicilloyl G

2-{[(5-carboxypentyl)-C-hydroxycarbonimidoyl][(1-hydroxy-2-phenylethylidene)amino]methyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylate

C22H31N3O6S (465.1933)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA

2-({4-[(2-azaniumyl-3-sulfanylpropyl)amino]-2-(naphthalen-1-yl)phenyl}formamido)-4-methylpentanoate

C26H31N3O3S (465.2086)


   

2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile

2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile

C28H27N5S (465.1987)


   
   

strictosidine lactam

strictosidine lactam

C25H27N3O6 (465.19)


   
   
   
   
   
   
   
   
   
   
   
   
   

Cys Cys Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylpentanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Cys Cys Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-3-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Cys Cys Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-4-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Cys Cys Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-methylpentanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Cys Ile Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Cys Ile Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Cys Lys Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Cys Lys Cys Leu

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Cys Lys Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Cys Lys Leu Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Cys Leu Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Cys Leu Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Cys Arg Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Cys Arg Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Cys Ser Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Cys Ser Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Cys Thr Arg Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Cys Thr Ser Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Phe Gly Gly Trp

(2S)-2-(2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C24H27N5O5 (465.2012)


   

Phe Gly Trp Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C24H27N5O5 (465.2012)


   

Phe Trp Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}acetic acid

C24H27N5O5 (465.2012)


   

Gly Phe Gly Trp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C24H27N5O5 (465.2012)


   

Gly Phe Trp Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C24H27N5O5 (465.2012)


   

Gly Gly Phe Trp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C24H27N5O5 (465.2012)


   

Gly Gly Trp Phe

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C24H27N5O5 (465.2012)


   

Gly Lys Met Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Gly Met Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Gly Met Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Gly Trp Phe Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]acetic acid

C24H27N5O5 (465.2012)


   

Gly Trp Gly Phe

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}-3-phenylpropanoic acid

C24H27N5O5 (465.2012)


   

Ile Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Ile Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Ile Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Lys Cys Cys Ile

(2S,3S)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Lys Cys Cys Leu

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C18H35N5O5S2 (465.208)


   

Lys Cys Ile Cys

(2R)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Lys Cys Leu Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Lys Gly Met Met

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Lys Ile Cys Cys

(2R)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   
   

Lys Leu Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Lys Met Gly Met

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Lys Met Met Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]acetic acid

C18H35N5O5S2 (465.208)


   

Leu Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Leu Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Leu Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H35N5O5S2 (465.208)


   

Met Gly Lys Met

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}hexanamido]-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Met Gly Met Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-4-(methylsulfanyl)butanamido]hexanoic acid

C18H35N5O5S2 (465.208)


   

Met Lys Gly Met

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C18H35N5O5S2 (465.208)


   

Met Lys Met Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-4-(methylsulfanyl)butanamido]acetic acid

C18H35N5O5S2 (465.208)


   

Met Met Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]acetamido}hexanoic acid

C18H35N5O5S2 (465.208)


   

Met Met Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]hexanamido]acetic acid

C18H35N5O5S2 (465.208)


   

Arg Cys Ser Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Arg Cys Thr Ser

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Arg Ser Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Arg Ser Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Arg Thr Cys Ser

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Arg Thr Ser Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Ser Cys Arg Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Ser Cys Thr Arg

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Ser Arg Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H31N7O7S (465.2006)


   

Ser Arg Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Ser Thr Cys Arg

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Ser Thr Arg Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Thr Cys Arg Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Thr Cys Ser Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Thr Arg Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H31N7O7S (465.2006)


   

Thr Arg Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Thr Ser Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7S (465.2006)


   

Thr Ser Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C16H31N7O7S (465.2006)


   

Trp Phe Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]acetamido}acetic acid

C24H27N5O5 (465.2012)


   

Trp Gly Phe Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-phenylpropanamido]acetic acid

C24H27N5O5 (465.2012)


   

Trp Gly Gly Phe

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)-3-phenylpropanoic acid

C24H27N5O5 (465.2012)


   

Biotripyrrin-b

Biotripyrrin-b

C25H27N3O6 (465.19)


   

Sarpogrelate Hydrochloride

Sarpogrelate Hydrochloride

C24H32ClNO6 (465.1918)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Sarpogrelate hydrochloride (MCI-9042) is a selective 5-HT2R antagonist, with pKis of 8.52, 6.57, and 7.43 for 5-HT2A, 5-HT2B, and 5-HT2C receptors, respectively. Sarpogrelate hydrochloride displays selectivity over 5-HT1, 5-HT3, 5-HT4, α1-, α2- and β-adrenoreceptor, histamine H1, H2 and muscarinic M3 receptors. Sarpogrelate hydrochloride can be used for the research of vascular disease associated with thrombosis[1][2][3].

   

TERT-BUTYL 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE

C22H31N3O6S (465.1933)


   

PF-543

Sphingosine Kinase 1 Inhibitor II

C27H31NO4S (465.1974)


D004791 - Enzyme Inhibitors

   

11-(PYRENE-1-SULFONYLAMINO)UNDECANOIC ACID

11-(PYRENE-1-SULFONYLAMINO)UNDECANOIC ACID

C27H31NO4S (465.1974)


   

2-CHLORO-5-NITROBENZAMIDE

2-CHLORO-5-NITROBENZAMIDE

C27H31NO4S (465.1974)


   

Acalabrutinib

Acalabrutinib

C26H23N7O2 (465.1913)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE

(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE

C27H31NO4S (465.1974)


   
   

CID 24906286

(2S)-2-[[[4-[[(2R)-2-amino-3-mercaptopropyl]amino]-2-(1-naphthalenyl)phenyl]-oxomethyl]amino]-4-methylpentanoic acid

C26H31N3O3S (465.2086)


   

Tert-Butyl 4-({[4-(But-2-Yn-1-Ylamino)phenyl]sulfonyl}methyl)-4-[(Hydroxyamino)carbonyl]piperidine-1-Carboxylate

Tert-Butyl 4-({[4-(But-2-Yn-1-Ylamino)phenyl]sulfonyl}methyl)-4-[(Hydroxyamino)carbonyl]piperidine-1-Carboxylate

C22H31N3O6S (465.1933)


   

Biotripyrrin-a

Biotripyrrin-a

C25H27N3O6 (465.19)


   

(Z,Z)-2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-2,5-dihydro-4-methyl-5-oxo-1H-Pyrrole-3-propanoate

(Z,Z)-2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-2,5-dihydro-4-methyl-5-oxo-1H-Pyrrole-3-propanoate

C25H27N3O6 (465.19)


   

N-[2-(tert-butylamino)-2-oxo-1-thiophen-2-ylethyl]-N-(2-oxolanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide

N-[2-(tert-butylamino)-2-oxo-1-thiophen-2-ylethyl]-N-(2-oxolanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide

C26H31N3O3S (465.2086)


   

5-[[2-[4-[1-(1,3-Dioxo-2-indenylidene)ethyl]-1-piperazinyl]ethylamino]methylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione

5-[[2-[4-[1-(1,3-Dioxo-2-indenylidene)ethyl]-1-piperazinyl]ethylamino]methylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione

C24H27N5O5 (465.2012)


   

Uroerythrin

Uroerythrin

C25H27N3O6 (465.19)


   
   
   
   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C26H28FN3O4 (465.2064)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C26H28FN3O4 (465.2064)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide

C21H31N5O5S (465.2046)


   

1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C26H28FN3O4 (465.2064)


   

1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C26H28FN3O4 (465.2064)


   
   
   
   
   
   
   
   
   
   

(2S)-2-[[[4-[[(2R)-2-amino-3-mercaptopropyl]amino]-2-(1-naphthalenyl)phenyl]-oxomethyl]amino]-4-methylpentanoic acid

(2S)-2-[[[4-[[(2R)-2-amino-3-mercaptopropyl]amino]-2-(1-naphthalenyl)phenyl]-oxomethyl]amino]-4-methylpentanoic acid

C26H31N3O3S (465.2086)


   

ST 21:4;O7;Gly

ST 21:4;O7;Gly

C23H31NO9 (465.1999)


   
   

5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C23H31NO9 (465.1999)


   

(1r,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

(1r,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C23H31NO9 (465.1999)


   

n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)(phenyl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid

n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)(phenyl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid

C29H27N3O3 (465.2052)


   

(1s,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

(1s,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C23H31NO9 (465.1999)